Skip to main content
. 2023 Jul 16;13(12):4138–4165. doi: 10.7150/thno.83066

Figure 3.

Figure 3

MSC-derived EVs for neurodegenerative diseases. MSC-derived EVs have gained significant attention as potential therapeutic agents for neurological diseases. It represents some information on their sources, isolation methods, biomarkers, and storage considerations. However, current researches are still evolving, and there may be additional developments and refinements in isolation methods, biomarker identification, and storage strategies as further research progresses.